000 01692 a2200409 4500
005 20250516234723.0
264 0 _c20160815
008 201608s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2013.50.1320
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarding, Damian J
245 0 0 _aSuccessful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cApr 2016
300 _ae97-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aDasatinib
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFusion Proteins, bcr-abl
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
_xadministration & dosage
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aLiver Failure, Acute
_xchemically induced
650 0 4 _aLiver Transplantation
650 0 4 _aProtein Kinase Inhibitors
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aMacQuillan, Gerry
700 1 _aHowman, Rebecca
700 1 _ade Boer, Bastian
700 1 _aAdams, Leon
700 1 _aMitchell, Andrew
700 1 _aJeffrey, Gary
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 34
_gno. 11
_gp. e97-8
856 4 0 _uhttps://doi.org/10.1200/JCO.2013.50.1320
_zAvailable from publisher's website
999 _c24233920
_d24233920